Skip links

Media

Media items re. PharmaCielo

Colombian Government Continues its Support of Domestic Cannabis Industry – Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo

March 1, 2024 TORONTO, Canada and RIONEGRO, Colombia (March 1, 2024) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today commented

PharmaCielo Announces Q3 2023 Financial Results

November 29, 2023 PharmaCielo Announces Q3 2023 Financial Results All figures in Canadian dollars ($) unless otherwise specified TORONTO and RIONEGRO, Colombia, November 29, 2023 – PharmaCielo Ltd. (“PharmaCielo” or the “Company“) (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer

pharmacielo

PharmaCielo Announces Q2 2023 Financial Results

August 29, 2023 PharmaCielo Announces Q2 2023 Financial Results All figures in Canadian dollars ($) unless otherwise specified TORONTO and RIONEGRO, Colombia, August 29, 2023 – PharmaCielo Ltd. (“PharmaCielo” or the “Company“) (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer